Related Experiment Videos
Menopausal hormone therapy does not influence lung cancer risk: results from the California Teachers Study
Jessica Clague1, Peggy Reynolds, Jane Sullivan-Halley
1Department of Population Sciences, Division of Cancer Etiology, Beckman Research Institute, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA.
Background:
Results from studies examining the association between hormone therapy (HT) and lung cancer risk disagree.
Methods:
We examined the associations between HT use and lung cancer risk among 60,592 postmenopausal women enrolled in the prospective California Teachers Study cohort. Between 1995 and 2007, a total of 727 women had a diagnosis of lung cancer. Multivariable Cox proportional hazards regression models were fit using age as the time metric.
Results:
No measure of HT use was associated with lung cancer risk (all P(trend) values ≥0.4). In addition, no variations in risk by smoking status (never, ever, former, current), type of HT [estrogen (E)-alone, E + progestin (P) use], type of menopause, or lung cancer histology were observed.
Conclusions:
Our findings do not support an association between HT and lung cancer.
Impact:
This large-scale, prospective study, which capitalizes on the detailed hormone use, smoking history, and type of menopause information available within this unique cohort, was unable to find any association between intake of HT and lung cancer risk.
Related Concept Videos
01:28Menopause
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:59Cancer Prevention
Some...